Trials / Completed
CompletedNCT03307031
The Influence of Pilates Exercises Training Volume on Metabolic Outcomes in Dyslipidemic Women.
The Influence of Pilates Exercises Training Volume on Metabolic, Physical Fitness and Quality of Life Outcomes in Dyslipidemic Women: A Controlled Clinical Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Federal University of Rio Grande do Sul · Academic / Other
- Sex
- Female
- Age
- 60 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study was to assess the influence of different volumes of Pilates training exercises on metabolic, blood pressure (BP), functional physical fitness (PF) and quality of life (QL) outcomes in postmenopausal dyslipidemic women. In total, 26 women participated in the controlled clinical trial, being allocated into three groups: high volume group (HVG; n=9), low volume group (LVG; n=11) and control group (CG, n=6). HVG performed four weekly sessions and LVG performed only twice a week, during 10 weeks with 45 to 55 minutes per session. Before and after the intervention period, metabolic, BP, PF, QL and cardiovascular risk score (CRS) outcomes were measured. The results were described by mean values with lower and upper limits (95% confidence interval). Comparisons between groups and intra-groups were performed adopting Generalized Estimating Equations (GEE) method, with post hoc of Bonferroni and significance level of ɑ=0,05.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High Volume Group | Performed four weekly session, during 10 weeks with 45 to 55 minutes per session. |
| OTHER | Low Volume Group | Performed only twice a week, during 10 weeks with 45 to 55 minutes per session. |
| OTHER | Control Group | Did not exercise, during 10 weeks. |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2017-07-28
- Completion
- 2017-09-13
- First posted
- 2017-10-11
- Last updated
- 2017-10-11
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03307031. Inclusion in this directory is not an endorsement.